DNA vaccination to treat autoimmune diabetes

References

• Hassett D E, Whitton J L. DNA Immunization. Trends Microbiol 1996; 4: 307–12
   PubMed Web of Science ®Google Scholar
• Donnelly J J, Ulmer J B, Liu M A. DNA vaccines. Life Sci 1997; 60: 163–72
   PubMed Web of Science ®Google Scholar
• MacGregor R R, Boyer J D, Ugen K E, Lacy K E, Gluckman S J, Bagarazzi M L, et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 1998; 178: 92–100
   PubMed Web of Science ®Google Scholar
• Tacket C O, Roy M J, Widera G, Swain W F, Broome S, Edelman R. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999; 17: 2826–9
   PubMed Web of Science ®Google Scholar
• Ramshaw L A, Fordham S A, Bernard C C, Maguire D, Cowden W B, Willenborg D O. DNA vaccines for the treatment of autoimmune disease. Immunol Cell Biol 1997; 75: 409–13
   PubMed Web of Science ®Google Scholar
• Ruiz P J, Garren H, Ruiz I U, Hirschberg D L, Nguyen L V, Karpuij M V, et al. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J Immunol 1999; 162: 3336–41
   PubMed Web of Science ®Google Scholar
• Whitton J L, Oldstone M BA. The immune response to viruses. Fields' Virology. 4th edn., B N Fields, D M Knipe, P M Howley. Lippincott Williams & Wilkins, Philadelphia, PA, in press
   Google Scholar
• Rodriguez F, Whitton J L. Enhancing DNA immunization. Virology, in press
   Web of Science ®Google Scholar
• Leitner W W, Ying H, Restifo N P. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999; 18: 765–77
   PubMed Web of Science ®Google Scholar
• Feltquate D M, Heaney S, Webster R G, Robinson H L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997; 158: 2278–84
   PubMed Web of Science ®Google Scholar
• Lobell A, Weissert R, Eltayeb S, Svanholm C, Olsson T, Wigzell H. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis. J Immunol 1999; 163: 4754–62
   PubMed Web of Science ®Google Scholar
• Coon B, An L -L, Whitton J L, von Herrath M G. DNA immunization to prevent autoimmune diabetes. J Clin Invest 1999; 104: 189–94
   PubMed Web of Science ®Google Scholar
• Svanholm C, Sandholtz L, Lobell A, Wigzell H. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. J Immunol Methods 1999; 228: 121–30
   PubMed Web of Science ®Google Scholar
• Homann D, Holz A, Bot A, Coon B, Wolfe T, Petersen J, et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999; 11: 463–72
   PubMed Web of Science ®Google Scholar
• Leitenberg D, Bottomly K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999; 11: 283–92
   PubMed Web of Science ®Google Scholar
• Tao X, Constant S, Jorritsma P, Bottomly K. Strength of TCR signal determines the costimulatory requirements for Thl and Th2 CD4+ T cell differentiation. J Immunol 1997; 159: 5956–63
   PubMed Web of Science ®Google Scholar
• Romball C G, Weigle W O. In vivo induction of tolerance in murine CD4+ cell subsets. J Exp Med 1993; 178: 1637–44
   PubMed Web of Science ®Google Scholar
• Miller J FAP. Role of the thymus in immunity - 30 years of progress. Immunologist 1993; 1: 9–13
   Google Scholar
• Ashton-Rickardt P G, Bandeira A, Delaney J R, Van Kaer L, Pircher H P, Zinkernagel R M, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994; 76: 651–63
   PubMed Web of Science ®Google Scholar
• Genain C, Lee-Parritz D, Nguyen M H, Massacesi L, Joshi N, Ferrante R, et al. In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. J Clin Invest 1994; 94: 1339–45
   PubMed Web of Science ®Google Scholar
• Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T-cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249–56
   PubMed Web of Science ®Google Scholar
• Abbas A K. Die and let live: eliminating dangerous lymphocytes. Cell 1996; 84: 655–7
   PubMed Web of Science ®Google Scholar
• Weiner H L, Friedman A, Miller A, Khoury S J, al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809–37
   PubMed Web of Science ®Google Scholar
• Weiner D B. New vaccine strategies. Mol Med Today 1995; 1: 108–9
   PubMedGoogle Scholar
• Kumer V, Sercarz E. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J Neurosci Res 1996; 45: 334–9
   PubMed Web of Science ®Google Scholar
• Wildner G, Thurau S R. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur J Immunol 1995; 25: 1292–7
   PubMed Web of Science ®Google Scholar
• Harding F A, Allison J P. CD28-B7 interactions allow the induction of CD8+ cytotoxic T-lymphocytes in the absence of exogenous help. J Exp Med 1993; 177: 1791–6
   PubMed Web of Science ®Google Scholar
• Gahring L C, Weigle W O. The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin. J Immunol 1989; 143: 2094–100
   PubMed Web of Science ®Google Scholar
• Bachmann M F, Rohere U H, Kundig T M, Burki K, Hengartner H, Zinkernagel R M. The influence of antigen organization on B cell responsiveness. Science 1993; 262: 1448–51
   PubMed Web of Science ®Google Scholar
• Murali-Krishna K, Altman J D, Suresh M, Sourdive D J, Zajac A J, Miller J D, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8: 177–87
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun S, Hwang I, Tough D F, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998; 8: 591–9
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Zhang J, Whitton J L. DNA immunization confers protection against lethal LCMV infection. J Virol 1995; 69: 2684–8
   PubMed Web of Science ®Google Scholar
• Rodriguez F, Zhang J, Whitton J L. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J Virol 1997; 71: 8497–503
   PubMed Web of Science ®Google Scholar
• Rodriguez F, An L -L, Harkins S, Zhang J, Yokoyama M, Widerg G, et al. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol 1998; 72: 5174–81
   PubMed Web of Science ®Google Scholar
• Fowler E, Weiner H L. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases. Biopolymers 1997; 43: 323–35
   PubMed Web of Science ®Google Scholar
• Refaeli Y, Van Parijs L, London C A, Tschopp J, Abbas A K. Biochemical mechanisms of IL-2-regulated fas-mediated T cell apoptosis. Immunity 1998; 8: 615–23
   PubMed Web of Science ®Google Scholar
• Aichele P, Brduscha-Riem K, Oehen S, Odermatt B, Zinkernagel R M, Hengartner H, et al. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 1997; 6: 519–29
   PubMed Web of Science ®Google Scholar
• Homann D, Dyrberg T, Petersen J, Apostolopoulos V, Oldstone M BA, von Herrath M G. Insulin in oral immune ‘tolerance’: a one-amino acid change in the B chain makes the difference. J Immunol 1999; 163: 1833–8
   PubMed Web of Science ®Google Scholar
• Maron R, Blogg N S, Polanski M, Hancock W, Weiner H L. Oral tolerance to insulin and the insulin B-chain: cell lines and cytokine patterns. Ann N Y Acad Sci 1996; 778: 357
   Web of Science ®Google Scholar
• Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 1996; 93: 2253–6
   PubMed Web of Science ®Google Scholar
• Moudgil K D, Sercan E E. The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin Immunol Immunopathol 1994; 73: 283–9
   PubMedGoogle Scholar
• von Herrath M G, Homann D. Treatment of virus-induced autoimmune diabetes by oral administration of insulin. Study on the mechanism by which oral antigens can abrogate autoimmunity. Endocrinol Diabetes 1997; 105: 24–5
   PubMedGoogle Scholar
• Nicholson L B, Murtaza A, Hafler B P, Sette A, Kuchroo V K. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc Natl Acad Sci USA 1997; 94: 9279–84
   PubMed Web of Science ®Google Scholar
• Bayrak S, Mitchison N A. Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide. Clin Exp Immunol 1998; 113: 92–5
   PubMed Web of Science ®Google Scholar
• Steinman L. Absence of ‘original antigenic sin’ in autoimmunity provides an unforeseen platform for immune therapy. J Exp Med 1999; 189: 1021–4
   PubMed Web of Science ®Google Scholar
• Delovitch T L, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes. Immune dysregulation gets the NOD. Immunity 1997; 7: 727–38
   PubMed Web of Science ®Google Scholar
• Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999; 189: 877–82
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Dyrberg T, Oldstone M BA. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996; 98: 1324–31
   PubMedGoogle Scholar
• Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317–26
   PubMed Web of Science ®Google Scholar
• Bergerot I, Arreaza G A, Cameron M J, Burdick M D, Strieter R M, Chensue S W, et al. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 1999; 48: 1720–9
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Dockter J, Oldstone M BA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994; 1: 231–42
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Oldstone M BA. Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. Trends Microbiol 1995; 3: 424–30
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Oldstone M B. Virus-induced autoimmune disease. Curr Opin Immunol 1996; 8: 878–85
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Oldstone M BA. IFN-gamma is essential for beta-cell destruction by CTL. J Exp Med 1997; 185: 531–9
   PubMed Web of Science ®Google Scholar
• von Herrath M G, Guerder S, Lewicki H, Flavell R, Oldstone M BA. Coexpression of B7.1 and viral (self) transgenes in pancreatic beta-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995; 3: 727–38
   PubMed Web of Science ®Google Scholar
• Whitton J L. Lymphocytic choriomeningitis virus CTL. Semin Virol 1990; 1: 257–62
   Google Scholar
• Slifka M K, Rodriguez F, Whitton J L. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 1999; 401: 76–9
   PubMed Web of Science ®Google Scholar
• Hanahan D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr Opin Immunol 1998; 10: 656–62
   PubMed Web of Science ®Google Scholar
• Smith K M, Olson D C, Hirose R, Hanahan D. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance. Int Immunol 1998; 10: 656–62
   Google Scholar
• Karin N, Binah O, Grabie N, Mitchell D J, Felzen B, Solomon M D, et al. Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease. J Immunol 1998; 160: 5188–94
   PubMed Web of Science ®Google Scholar
• Kumar V, Aziz F, Sercarz E, Miller A. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen 11-induced arthritis and experimental autoimmune encephalomyelitis. J Exp Med 1997; 185: 1725–33
   PubMed Web of Science ®Google Scholar
• Kumar V, Sercarz E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J Immunol 1998; 161: 6585–91
   PubMed Web of Science ®Google Scholar
• Weissert R, Lobell A, deGraaf K L, Eltayeb S Y, Anderson R, Olsson T, et al. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen. Proc Natl Acad Sci U S A 2000; 97: 1689–94
   PubMed Web of Science ®Google Scholar
• Harrison L C, Honeyman M C, DeAizpurua H J, Schmidli R S, Colman P G, Tait B D, et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365–79
   PubMed Web of Science ®Google Scholar
• Redondo M J, Rewers M, Yu L, Garg S, Pitcher C C, Elliott R B, et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 1999; 318: 698–702
   PubMedGoogle Scholar
• Jackson R A, Soeldner J S, Eisenbarth G S. Predicting insulindependent diabetes. Lancet 1988; 10: 627–8
   Google Scholar
• Blanas E, Carbone F R, Allison J, Miller J F, Heath W R. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996; 274: 1707–9
   PubMed Web of Science ®Google Scholar